"Value enhancing strategic and financial solutions for Life Science companies"
Akesios Associates was established to provide commercial support and representation for growing Life Science companies.
We believe these companies will continue to represent an increasingly vital source of innovation, with potential to revolutionise the treatment of disease.
In addition to its corporate development skills, Akesios can draw upon a network of companies and individuals with access to appropriate expertise to navigate a broad range of functions, including fund-raising, licensing and M&A.
Akesios is headed by Dr Shawn Manning, with over 25 years of international Life Sciences experience, including over 12 years as a rated equity analyst (with Dresdner Kleinwort Benson, Société Generale, Bridgewell/ Landsbanki and Singer Capital Markets), covering ‘Big Pharma’, speciality/emerging pharmaceutical, and biotechnology stocks. Over the last 5 years Manning’s research supported the raising of over £200m in new funding for Life Science companies.
Before entering the City of London, Manning spent 5 years consulting to the pharmaceutical industry, and managing Datamonitor's Healthcare practice. In this capacity he worked alongside major European, US and Japanese pharmaceutical companies, focusing primarily on strategic product positioning, including portfolio, opportunity and pricing analysis. Manning originally specialised in infectious disease, and holds a Doctorate from the University of Oxford, and a BSc (Hons) from Imperial College, London. He is a Fellow of the Royal Society of Medicine.
